LYN is in many ways involved in cancer as an oncotarget in cervical cancer37, associated with poor prognosis in renal cancer38, and as a response predictor to dasatinib in lung adenocarcinoma subpopulations39. The gene discussed is LYN; the disease is lung adenocarcinoma.